Cargando…

Potential roles of N6-methyladenosine (m6A) in immune cells

N6-methyl-adenosine (m6A) is one of the most common internal modifications on RNA molecules present in mammalian cells. Deregulation of m6A modification has been recently implicated in many types of human diseases. Therefore, m6A modification has become a research hotspot for its potential therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chang, Yang, Zhe, Li, Rong, Wu, Yanju, Chi, Ming, Gao, Shuting, Sun, Xun, Meng, Xin, Wang, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186046/ https://www.ncbi.nlm.nih.gov/pubmed/34103054 http://dx.doi.org/10.1186/s12967-021-02918-y

Ejemplares similares

Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022)

Regulation of Antiviral Immune Response by N(6)-Methyladenosine of mRNA
por: Zhao, Baoxin, et al.
Publicado: (2021)

N(6)-methyladenosine (m(6)A) RNA modification in tumor immunity
por: Zheng, Siyi, et al.
Publicado: (2022)

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
por: Zhai, Ganggang, et al.
Publicado: (2022)

The role of N6-methyladenosine (m(6)A) in kidney diseases
por: You, Luling, et al.
Publicado: (2023)

The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis
por: Chen, Mengnuo, et al.
Publicado: (2020)

m(6)A-Atlas: a comprehensive knowledgebase for unraveling the N(6)-methyladenosine (m(6)A) epitranscriptome
por: Tang, Yujiao, et al.
Publicado: (2020)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology
por: Malovic, Emir, et al.
Publicado: (2021)

Roles and implications of mRNA N(6) ‐methyladenosine in cancer
por: Zeng, Lingxing, et al.
Publicado: (2023)

Emerging role of RNA modification N6-methyladenosine in immune evasion
por: Lou, Xin, et al.
Publicado: (2021)

Widespread occurrence of N(6)-methyladenosine in bacterial mRNA
por: Deng, Xin, et al.
Publicado: (2015)

N6-methyladenosine methylation in kidney injury
por: Wang, Qimeng, et al.
Publicado: (2023)

Critical Roles of N(6)-Methyladenosine (m(6)A) in Cancer and Virus Infection
por: Asada, Ken, et al.
Publicado: (2020)

The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs
por: Zhang, Lele, et al.
Publicado: (2020)

Roles of N(6)‐methyladenosine (m(6)A) RNA modifications in urological cancers
por: Wang, Xiao, et al.
Publicado: (2020)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma
por: Qu, Nanfang, et al.
Publicado: (2021)

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022)

The Potential Roles of RNA N6-Methyladenosine in Urological Tumors
por: Li, Yang, et al.
Publicado: (2020)

The potential role of RNA N6-methyladenosine in Cancer progression
por: Wang, Tianyi, et al.
Publicado: (2020)

N(6)-Methyladenosine and Viral Infection
por: Dang, Wei, et al.
Publicado: (2019)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Emerging Perspectives of RNA N(6)-methyladenosine (m(6)A) Modification on Immunity and Autoimmune Diseases
por: Tang, Lipeng, et al.
Publicado: (2021)

N6-Methyladenosine (m6A) Modification in Natural Immune Cell-Mediated Inflammatory Diseases
por: Teng, Yan, et al.
Publicado: (2023)

Viral and Cellular N(6)-Methyladenosine (m(6)A) and N(6), 2′-O-Dimethyladenosine (m(6)Am) Epitranscriptomes in KSHV Life Cycle
por: Tan, Brandon, et al.
Publicado: (2017)

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022)

N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
por: Jin, Huan, et al.
Publicado: (2019)

Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract
por: Cai, Lei, et al.
Publicado: (2023)

Structural Insights into N(6)-methyladenosine (m(6)A) Modification in the Transcriptome
por: Huang, Jinbo, et al.
Publicado: (2018)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

N(6)-methyladenosine (m(6)A) methylation in ischemia–reperfusion injury
por: Yao, Weifeng, et al.
Publicado: (2020)

The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma
por: He, Cheng, et al.
Publicado: (2023)

circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion
por: Zhang, Yonggang, et al.
Publicado: (2021)

The role of RNA N(6)-methyladenosine methyltransferase in cancers
por: Huang, Jiali, et al.
Publicado: (2021)

Interaction between N(6)-methyladenosine (m(6)A) modification and noncoding RNAs in cancer
por: Chen, Yi, et al.
Publicado: (2020)

N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions
por: Du, Bingying, et al.
Publicado: (2021)

The Mechanism and Role of N(6)-Methyladenosine (m(6)A) Modification in Atherosclerosis and Atherosclerotic Diseases
por: Tan, Quandan, et al.
Publicado: (2022)

The Roles of N(6)-Methyladenosine in Human Diseases
por: An, Shanshan, et al.
Publicado: (2019)

The Role of N(6)-Methyladenosine in Inflammatory Diseases
por: Xu, Haojun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4gsruhtouubh5er3q74hcab69r